Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

How can we exploit the brain's ability to repair itself?
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.
Evaluation of Inner Retinal Layers in Patients with Multiple Sclerosis or Neuromyelitis Optica Using Optical Coherence Tomography.
Stretching the limbs? Tonic spasms in multiple sclerosis.
Short-term safety of pulse steroid therapy in multiple sclerosis relapses.
Diagnostic uncertainty of tumefactive cystic demyelinating lesions.
Potential Beneficial Effects of Marine Peptide on Human Neuron Health.
Prediction of risk of fracture in the tibia due to altered bone mineral density distribution resulting from disuse: A finite element study.
Targeting IL-10 in Auto-immune Diseases.
Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
Vestibular-evoked myogenic potentials, clinical evaluation, and imaging findings in multiple sclerosis.
Multiple sclerosis: Effect of smoking on antibody response to IFN-β treatment.
Improving the quality of mental health care in Multiple Sclerosis.
RECENT ADVANCES IN MESENCHYMAL STEM CELL IMMUNOMODULATION. THE ROLE OF MICROVESICLES.
G protein-coupled receptors as therapeutic targets for multiple sclerosis.
Clinical profile and aetiology of optic neuritis in Hospital Universiti Sains Malaysia--5 years review.
Prodrugs of fumarate esters for the treatment of psoriasis and multiple sclerosis-a computational approach.
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.
[Of worms and men--Administration of helminth products as an innovative approach to treatment of autoimmune diseases].
The Latest Innovations in the Drug Pipeline for Multiple Sclerosis.
Comparison of Magnetic Susceptibility Tensor and Diffusion Tensor of the Brain.
The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS.
Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus.
Molecular pathogenesis of neuromyelitis optica.
Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis.

Pages